Effects of calcium on the migration and recruitment of macrophages and macrophage-derived foam cells

FASEB Journal

Volumn 10, Issue 4, 1996, Pages 491-501

  Shi, Hao ^a   Severs, Nicholas J ^b   Robenek, Horst ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

atherosclerosis; Boyden chamber; isradipine; lipoprotein; macrophage foam cell

Indexed keywords

ACETYL LOW DENSITY LIPOPROTEIN; CALCIUM; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CALCIFICATION; CELL AGGREGATION; CHEMOTAXIS; CONTROLLED STUDY; FOAM CELL; IN VITRO STUDY; MACROPHAGE MIGRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0029925494     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fasebj.10.4.8647348     Document Type: Article

References (60)

1. Wissler, R. W.(1992) Theories and new horizons in the pathogenesis of atherosclerosis and the mechanisms of clinical effects. Arch. Pathol. Lab. Med. 116, 1281-1291
2. Ross, R.(1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature (London) 362, 801-809
3. Ross, R.(1993) Atherosclerosis: curient understanding of mechanisms and future strategies in therapy. Transplant. Proc. 25, 2041-2043
4. Ross, R.(1995) Cell biology of atherosclerosis. Annu. Rev. Physiol. 57, 791-804
5. Campbell, A. K.(1983) Intracellular Calcium. Its Unuersal Role as Regulator, Wiley, New York
6. Nayler, W. G.(1991) Second Generation of Calcium Antagonists, Springer-Verlag, Berlin
7. 2+ channel blockers. Atherosclerosis 88, 109-132
8. Charo, I. F., Myers, S. J., Herman, A., Fianci, C., Connolly, A. J., and Coughlin, S. R. (1991) Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails. Proc. Natl. Acad. Sci. USA 91, 2752-2756
9. Comad, D. J., Kuhn, H., Mulkins, M., Highland, E., and Sigal, E. (1992) Specific inflammatory cytokines regulate the expression of human monocyte 15-lipoxygenase. Proc. Natl. Acad. Sci. USA 89, 217-221
10. Fleckenstein-Grun, G., and Flcekenstein, A. (1991) Calcium - A neglected key factor in atherosclerosis. The pathogenic role of arterial calcium overload and its prevention by calcium antagonists. Ann. Med. 23, 589-599
11. Nayler, W. G.(1992) The antiatherogenic effects of amlodipine: promise of preclinical data. J. Human Hypertension 6 (Suppl. 1), S19-S23
12. Blumenthal, H. T., Lansing, A. I., and Wheeler, P. A. (1944) Calcification of the media of the human aorta and its relation to intimal atherosclerosis, ageing and disease. Am. J. Pathol. 20, 665-687
13. Takeo, S., Anan, M., Fujioka, K., Kajihara, T., Hiraga, S., and Miyake, K. (1989) Functional changes of aorta with massive accumulation of calcium. Atherosclerosis 77, 175-181
14. Witteman, J. C., Kannel, W. B., Wolf, P. A., Grobbee, D. E., Hofman, A., and D'Agostino, R. B. (1990) Aortic calcified plaques and cardiovascular disease (The Framingham Study). Am. J. Cardiol. 66, 1060-1064
15. Falk, E.(1992) Why do plaques rupture. Circulation 86 (Suppl. III), 30-42
16. Schmid, K., McSharry, W. O., Pameijer, C. H., and Binette, J. P. (1980) Chemical and physicochemical studies on the mineral deposits of the human atherosclerotic aorta. Atherosclerosis 37, 199-210
17. O'Brien, E. R., Garvin, M. R., Stewart, D. K., Hmohara, T., Simpson, J. B., Schwartz, S. M., and Giachelli, C. M. (1994) Osteopontin is synthesized by macrophage, smooth muscle, and endothelial cells in primary and restenotic human coronary atheroscleiotic plaques. Arterioscler. Thromb. 14, 1648-1656
18. Fitzpatrick, L. A., Severson, A., Edwaids, W. D., and Ingram, R. T. (1994) Diffuse calcification in human coronary arteries. Association of osteopontin with atherosclerosis. J. Clin. Invest. 94, 1597-1601
19. Shanahan, C. M., Cary, N. R., Metcalfe, J. C., and Weissberg, P. L. (1994) High expression of genes for calcification-regulating proteins in human atherosclerotic plaques. J. Clin. Invest. 93, 2393-2402
20. Triggle, D. J. (1991) Calcium channel antagonists: sites, control and mechanisms of action relevant to the atherosclerotic process. In Calcium Antagonism and Atherosclerosis (Born, G. V. R., ed) pp, 27-41, Science Press Ltd, London
21. Born, G. V. R. (1991) Calcium and atherosclerosis. In Calcium Antagonism and Atherosclerosis (Born, G. V. R., ed) pp. 1-26, Science Press Ltd, London
22. Henry, P. D.(1990) Calcium antagonists as antiatherosclerotic agents. Atherosclerosis 10, 963-965
23. Henry, P. D.(1991) Antiperoxidative actions of calcium antagonists and atherogenesis. J. Cardiovasc. Pharmacol. 18 Suppl. 1, S6-S10
24. Nayler, W. G.(1992) Calcium, calcium antagonism, atherosclerosis, and ischemia. J. Cardiovasc Pharmacol. 19 Suppl. 2, S17-S21
25. Lichtlen, P. R., Hugenholtz, P. C., Raffllenbeul, W., Hecker, H., Jost, S., Nikutta, P., and Deckers, J. W. (1990) Retardation of coronary artery disease in humans by the calcium-channel blocker nifedipine results of the INTACT study (International Nifedipine Trial on Antiatherosclerotic Therapy). Cardiovasc. Drugs Ther. 4, 1017-1068
26. Waters, D., and Lespérance, J. (1992) Interventions that beneficially influence the evolution of coronary atherosclerosis: The case for calcium channel blockers. Circulation 86 Suppl., 111-116
27. Sarig, S., Weiss, T. A., Katz, I., Kahana, F., Azoury, R., Okon, E., and Kruth, H. S. (1994) Detection of cholesterol associated with calcium mineral using confocal fluorescence microscopy. Lab. Invest. 71, 782-787
28. Meyer, W. W., and Lind, J. (1971) Calcification of arteries: frequent finding in childhood. Monatsschr.-Kinderheilkd. 119, 298-300
29. Schwartz, C J., Valente, A. J., Sprague, E. A., Kelley, J. L., Cayatte, A. J., and Mowery, J. (1992) Atherosclerosis: potential targets for stabilization and regression. Circulation 86 Suppl., 117-123
30. Fisher, M.(1991) Atherosclerosis: cellular aspects and potential interventions. Cerebrovasc. Brain Metab. Rev. 3, 114-133
31. Handley, D. A., Van Valen, R. G., Melden, M. K., and Saunders, R. N. (1986) Supression of rat carotid lesion development by the calcium channel bloeker PN-200-110. Am. J. Pathol 124, 88-93
32. Habib, J. B., Bossaller, C., and Wells, S. (1986) Preservation of endothelial-dependent vascular relaxation in cholesterol-fed rabbits by treatment with calcium blocker PN-200-110. Circ. Res. 58, 305-309
33. Basu, S. K., Goldstein, J. L., Anderson, G. W., and Brown, M. S. (1976) Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts. Proc. Natl. Acad. Sci. USA 73, 3178-3182
34. Steinbrecher, U. P., Parthasarathy, S , Leake, D. S., Witztum, J. L., and Steinberg, D. (1984) Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoproteins. Proc. Natl. Acad. Sci. USA 81, 3883-3887
35. Schuh, J., Faiiclough, G. F., and Hasehemeyer, R. H. (1978) Oxygen-mediated heterogeneity of apo-low-density lipoprotein. Proc. Natl. Acad. Sci. USA 75, 3173-3177
36. Ho, Y. K., Brown, M. S., and Goldstein, J. L. (1980) Hydrolysis and excietion of cytoplasmic cholesteryl esters by macrophages: Stimulation by high density lipoproteins and other agents. J. Lipid Res. 21, 391-398
37. Robenek, H., and Schmitz, G. (1985) Receptor domains in the plasma membrane of cultured mouse peritoneal macrophages. Eur. J. Cell Biol. 39, 77-85
38. Schmitz, G., Robenek, H., Lohmann, U., and Assmann, G. (1985) Interaction of high density lipoproteins with cholesteryl ester-laden macrophages: biochemical and morphological characterization of cell surface receptor binding, endocytosis and resecretion of high density lipoproteins by macrophages. EMBO J. 4, 613-622
39. Fleckenstein, A.(1983) Histoiy of calcium antagonists. Circ. Res. 52 (Suppl. I), 3-16
40. Fleckenstein, A., Frey, M., and Fleckenstein-Grün, G. (1986) Antihypertensive and arterial anticalcinotic effects of calcium antagonists. Am. J. Cardiol. 57, 1D-10D
41. Pauletto, P., Sartore, S., Giuriato, L., Scatena, M., Tonello, M., Scannapieco, C., Pessina, A. C., and Dal Palù, C. (1992) Calcium antagonists and vascular smooth muscle cells in atherogenesis. J. Cardiovasc. Pharmacol. 19 Suppl. 2, S8-S16
42. Cerrity, R. C.(1981) The role of the monocyte in atherogenesis. I. Transition of blood-borne monocytes into foam cells in fatty lesions. Am. J. Pathol. 103, 181-190
43. Gerrity, R. G.(1981) The role of the monocyte in atherosclerosis. II. Migration of foam cells from atherosclerotic lesions. Am. J. Pathol. 103, 191-200
44. Pataki, M., Lusztig, G., and Robenek, H. (1992) Eudocytosis of oxidized LDL and reversibility of migration inhibition in macrophage-derived foam cells in vitro. A mechanism for atherosclerosis regression? Arterioscler. Thromb. 12, 936-944
45. Kodama, T., Freeman, M., Rohret, L., Zabrecky, J., Matsudaira, P., and Krieger, M. (1990) Type I macrophage scavenger receptor contains α-helical and collagen-like coiled coils. Nature (London) 343, 531-535
46. Rohrer, L., Freeman, M., Kodama, T., Penman, M., and Krieger, M. (1990) Coiled-coil fibrous domains mediate ligand binding by macrophage scavenger receptor type II. Nature (London) 343, 570-572
47. Palinski, W., Rosenfeld, M. E., Ylä-Hertluala, S., Curtner, G. C., Scoher, S. S., Butler, S. W., Parthasarathy, S., Carew, T. E., Steinberg, D., and Witztum, J. L. (1989) Low density lipoprotein undergoes oxidative modification in vivo. Proc. Natl. Acad. Sci. USA 86, 1372-1376
48. Witztum, J. L.(1991) The role of oxidized LDL in atherosclerosis. Adv. Exp. Med. Biol. 285, 353-365
49. Parthasarathy, S., Steinberg, D., and Witztum, J. L. (1992) The role of oxidized low-density lipoproteine in the pathogenesis of atherosclerosis. Annu. Rev. Med. 43, 219-225
50. Henricksen, T , Mahoney, E. M., and Steinberg, D. (1983) Enhanced macrophage degradation of biologically modified low density lipoprotein. Arteriosclerosis 3, 149-159
51. Kita, T., Nagano, Y., Yokode, M., Ishii, K., Kume, N., Ooshima, A., Yoshida, H., and Kawai, C. (1987) Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. Proc. Natl. Acad. Sci. USA 84, 5928-5931
52. Hara, S., Nagano, Y., Sasada, M., and Kita, T. (1992) Probucol pretreatment enhances the chemotaxis of mouse peritoneal macrophages. Arterioscler. Thromb. 12, 593-600
53. Weisser, B., Locher, R., Mengden, T., and Vetter, W. (1992) Oxidation of low density lipoprotein enhances its potential to increase intracellular free calcium concentration in vascular smooth muscle cells. Arterioscler. Thromb. 12, 231-236
54. 2+ stores in human macrophages. J. Membr. Biol. 146, 101-111
55. Daugherty, A., Rateri, D. L., Schonfeld, G , and Sobel, B. E. (1987) Inhibition of cholesteryl ester deposition in macrophages by calcium entry blockers: an effect dissociable from calcium entry blockade. Br. J. Pharmacol. 91, 113-118
56. Nomoto, A., Hirosumi, J., and Sekiguchi, C. (1987) Antiatherogenic activity of FR34235 (nilvadipine), a new potent calcium antagonist. Atherosclerosis 64, 255-261
57. ++ antagonist and ACAT inhibitors promote cholesterol efflux. from macrophages by different mechanisms. I. Characterization of cellular lipid metabolism. Arteriosclerosis 8, 45-56
58. ++ antagonist and ACAT inhibitors promote cholesterol efflux from macrophages by different mechanisms. II. Characterization of intracellular morphologic changes. Arteriosclerosis 8, 57-67
59. Bernini, F., Bellosta, S., Didoni, G., and Fumagalli, R. (1991) Calcium-antagonists and cholesteryl ester metabolism in macrophages. J. Cardiovasc. Pharmacol. 18, s42-s45
60. Dushkin, M. I., and Ivanova, M. V. (1991) Metabolism of cholesterol esters in cultured macrophages under the action of the calcium-channel blockers verapamil and nifedipine. Biochemistry Russia 56, 551-557